GL1X · GenesisL1 explorer

Research workbench

The heterotrimeric complex of kluyveromyces lactis SCM3, CSE4 and H4

Analyse The heterotrimeric complex of kluyveromyces lactis SCM3, CSE4 and H4 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2YFV
Type
protein
Length
202 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone H3-like centromeric protein CSE4; Histone H4; SCM3
UniProt
Q6CTI2, Q6CMU6, Q6CL77
Ligands
IOD
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 3 distinct chains · 65% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone H3-like centromeric protein CSE4protein6874% helix, 6% strandQ6CTI2
BHistone H4protein7469% helix, 5% strandQ6CMU6
CSCM3protein6050% helix, 13% strandQ6CL77

Ligands and binding sites

  • IOD · Iodide ion · ion · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11170.480.7918IOD
2830.360.7614empty

Interfaces

3 interfaces between chains.

  • A–B · 2000 Ų buried · 11 hydrogen bonds · protein-protein
  • A–C · 976 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 472 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 2YFV · The heterotrimeric complex of Kluyveromyces lactis Scm3, Cse4 and H4 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6CTI2 · AlphaFold monomer V2.0 prediction for histone H3-like centromeric protein CSE4 (Q6CTI2) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.